$47.91
-$0.58
(-1.20%)
Quote as of 4:02 PM EST on 02/10/12
Valeant Pharmaceuticals Intern...
NYSE:VRX
|
$47.91
-$0.58
(-1.20%)
|
|
| Today's Open | $48.03 |
|---|---|
| Previous Close | $48.49 |
| Daily Range | $47.80 - $48.20 |
| 52-Week Range | $32.05 - $57.24 |
| Market Cap | $14.75B |
| P/E Ratio | 131.05 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 1,036,128 |
| Average Daily Volume | 2,106,491 |
| Current FY EPS | $2.96 |
VRX Information
| Description |
|---|
| A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
Valeant Pharma Withdraws Bid For Drug-Maker ISTA Pharma
UPDATE: Valeant Pharma Withdraws Bid For ISTA Pharma
The Stock Making Buffett’s Pals at the Sequoia Fund Rich: Valeant Pharmaceuticals
Buffett’s Pals at Sequoia Fund Own Less Berkshire, But Find Plenty of Winning Stocks
Valeant Pharma Sees 2012 Earnings Above Street Estimates
Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals
5 of Last Week's Biggest Winners
